Skip to content
OpenCapital
Get started

Albertsons Companies ACI Pharmacy — Net sales and other revenue

Other product segments

Non-perishables
$10.05B+6.0%
Fresh
$6.37B+7.1%
Fuel
$809.1M-1.7%
Other
$332.5M+17.9%

Similar metrics at other companies

CVS Health logo
CVSPharmacy — Revenues from external customers
$56.94B+8.4%
Baxter International logo
BAXPharmaceuticals — Net Sales
$621M+6.9%
CVS Health logo
CVSPharmacy & Consumer Wellness — Revenue
$31.99B+0.2%
AptarGroup logo
ATRPharma — Net Sales
$438.91M+7.1%
Mirum Pharmaceuticals, Inc. logo
MIRMProduct sales, net — Product sales, net
$159.88M+43.3%
Vertex Pharmaceuticals logo
VRTXPharmaceuticals — Product revenues, net
$2.99B+7.8%

Other financials

Income statement

See full
Revenue$20.3B+7.7%
Gross profit$5.5B+7.1%
Operating income$489.7M-5.6%
Net income$293.3M-26.8%
EPS (diluted)$0.55-20.3%

Balance sheet

See full
Cash & equivalents$198.6M-33.3%
Total debt$15.7B+7.1%
Total equity$1.8B-45.8%
Total assets$26.8B0.0%

Cash flow

See full
Operating cash flow$717.1M-5.5%
CapEx$426.6M-12.0%
Free cash flow$290.5M+6.0%

Valuation

See full
Market cap$6.65B-24.5%
Enterprise value$22.16B-7.0%
P/S0.1×0.0×

Profitability

See full
Gross margin27.2%-0.5pp
Operating margin1.9%-0.7pp
Net margin1.2%-0.4pp
FCF margin-0.8%—

Returns & leverage

See full
Return on equity31.3%-28.2pp
Debt / equity8.6×+4.2×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Albertsons Companies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Albertsons Companies’s 10-K, filed April 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Albertsons Companies's pharmacy — net sales and other revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Albertsons Companies's pharmacy — net sales and other revenue?
Albertsons Companies (ACI) reported pharmacy — net sales and other revenue of $2.69B in Q4 2025.
How has Albertsons Companies's pharmacy — net sales and other revenue changed year-over-year?
Albertsons Companies's pharmacy — net sales and other revenue increased by 18.9% year-over-year, from $2.26B to $2.69B.
What is the long-term trend for Albertsons Companies's pharmacy — net sales and other revenue?
Over 4 years (2021 to 2025), Albertsons Companies's pharmacy — net sales and other revenue has grown at a 18.3% compound annual growth rate (CAGR), from $5.82B to $11.41B.
What does pharmacy — net sales and other revenue mean?
This metric captures the total gross revenue generated from the pharmacy segment, including the sale of prescription medications, over-the-counter health products, and clinical pharmacy services. It serves as a primary indicator of the segment's market reach and consumer demand for healthcare offerings within the retail footprint. Growth in this figure highlights the company's ability to capture share in the competitive retail pharmacy and health services market.